Clinical Trial Update: A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 [Phase 3]

View source ↗

Summary

Phase 3 trial of relamorelin in diabetic gastroparesis was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Gastroparesis

Drugs mentioned

• Relamorelin (relamorelin)

Snippet

Sponsor: Allergan | Conditions: Gastroparesis, Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-12-22